O1-05-07 Behavioral benefits with continued donepezil treatment in Alzheimer's disease patients

Autor:	E. Triau, N. Kumar, G. Jakab, C.J. Kalisvaart, Alexander Kurz, Y. Xu, Peter Johannsen, L. Bergendorff, S. Richardson, W. Kozubski, Magda Tsolaki, S. Jakobsen, R. Holub
Rok vydání:	2004
Předmět:	Aging medicine.medical_specialty business.industry General Neuroscience Internal medicine medicine Neurology (clinical) Disease Geriatrics and Gerontology Donepezil business Developmental Biology medicine.drug
Zdroj:	Neurobiology of Aging. 25:S20
ISSN:	0197-4580
DOI:	10.1016/s0197-4580(04)80066-6
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::283c7da1a83298930b29f7858462b047 https://doi.org/10.1016/s0197-4580(04)80066-6 Zobrazit plný text záznamu Full Text from ScienceDirect